Is Narcolepsy Type 1 Hereditary? Should Relatives Get Tested?
At a Glance
Narcolepsy type 1 is usually not directly inherited. Family members have a slightly higher risk, but the overall risk remains low, so routine genetic testing of people without symptoms is not useful for prediction. Watch for symptoms and seek a sleep evaluation if they appear.
In this answer
3 sections
It is completely natural to worry about passing narcolepsy to your children or to wonder whether your siblings should be screened. The short answer is no, narcolepsy type 1 (NT1) is rarely directly inherited from a parent, and routine genetic testing for family members who do not have symptoms is not recommended. While having a relative with NT1 does increase a person’s risk slightly compared to the general population, the absolute risk remains very low [1]. Most people with NT1 do not have a family history of the disease.
The Difference Between Susceptibility and Inheritance
Narcolepsy type 1 is considered a complex, multifactorial condition rather than a simple inherited disorder [1]. This means that while genetic susceptibility sets the stage, it does not dictate the outcome.
Nearly all people with NT1 carry a specific genetic marker (or HLA allele) called HLA-DQB1*06:02 [2]. However, this marker is incredibly common, appearing in about 25% to 28% of the general population, though this prevalence varies by ancestry [3][4]. Having this marker simply means a person is more susceptible; it is neither necessary nor sufficient by itself to cause the disease [2].
The low familial risk is best demonstrated by twin studies. Even in identical twins, who share the exact same DNA, if one twin has NT1, the other twin will develop the condition only about 33% of the time [5]. It is widely believed that NT1 involves an immune-mediated loss of hypocretin-producing neurons in the brain, and that environmental factors may contribute to triggering the disease in genetically susceptible people [2]. However, the exact trigger is often unknown, and many patients cannot identify a specific event (like an infection) that caused their condition [5].
Why Testing Asymptomatic Relatives Isn’t Helpful
Because the HLA-DQB1*06:02 allele is so common, a positive blood test in a family member who feels fine cannot predict whether they will ever develop narcolepsy [6][7]. A positive result would only show that they, like a quarter of the general population, carry a susceptibility marker [3]. Conversely, a negative test reduces the likelihood but does not entirely eliminate the possibility of developing the condition [3][8].
As a result, routine HLA testing for unaffected family members does not predict who will develop NT1 well enough to guide prevention, and it often causes unnecessary worry [6].
What Family Members Should Do Instead
Instead of genetic screening, the most practical approach is symptom awareness. Symptoms usually appear during adolescence or young adulthood, but they can also start in childhood. Relatives should consult a primary care doctor or sleep specialist if they experience:
- Excessive daytime sleepiness: An irresistible need to sleep or unintentional sleep episodes during the day, not just ordinary tiredness. In children, this may look like irritability, hyperactivity, or resuming unplanned naps [9].
- Cataplexy: Sudden, brief episodes of muscle weakness triggered by strong emotions like laughter, surprise, or anger [9].
- Sleep paralysis: A temporary inability to move or speak while falling asleep or waking up [9].
- Sleep-related hallucinations: Vivid, sometimes frightening dreams or visions when transitioning between sleep and wakefulness. These occur at the edge of sleep and do not indicate psychosis [9].
(Safety Note: Anyone experiencing uncontrollable sleep episodes or unexplained daytime sleepiness should avoid driving or operating dangerous machinery until evaluated by a doctor).
If a family member develops these symptoms, a clinical evaluation is appropriate [10]. Diagnosing NT1 relies on clinical symptoms and objective sleep studies, such as polysomnography (an overnight sleep study) and a multiple sleep latency test (a daytime nap study) [9][11]. A specialist may sometimes measure hypocretin levels in the spinal fluid. Not every test is required for every patient, and a sleep specialist will choose the appropriate work-up.
While the vast majority of NT1 cases are not directly inherited, rare familial cases with multiple affected relatives or unusual early-onset symptoms do exist. In those specific situations, genetic counseling may be discussed [12].
Common questions in this guide
Is narcolepsy type 1 passed down from parents to children?
Should relatives without symptoms have genetic testing for narcolepsy?
What signs of narcolepsy should family members watch for?
Does carrying HLA-DQB1*06:02 mean someone will develop narcolepsy type 1?
How is narcolepsy type 1 diagnosed if a relative develops symptoms?
When might a family need genetic counseling for narcolepsy?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Family testing
Should my relatives be tested if they have no symptoms?
About genetic markers
Would a blood test for the HLA marker predict whether my relatives will develop narcolepsy?
Symptoms to watch for
What symptoms should my relatives watch for before seeing a doctor?
Related questions
Show more
Get notified when new evidence is published on narcolepsy 1.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
Genetics of narcolepsy.
Miyagawa T, Tokunaga K
Human genome variation 2019; (6()):4 doi:10.1038/s41439-018-0033-7.
PMID: 30652006 - 2
Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy.
Ollila HM, Sharon E, Lin L, et al.
Nature communications 2023; (14(1)):2709 doi:10.1038/s41467-023-36120-z.
PMID: 37188663 - 3
Correlation between HLA-DQB1*06:02 and narcolepsy with and without cataplexy: approving a safe and sensitive genetic test in four major ethnic groups. A systematic meta-analysis.
Capittini C, De Silvestri A, Terzaghi M, et al.
Sleep medicine 2018; (52()):150-157 doi:10.1016/j.sleep.2018.08.024.
PMID: 30321823 - 4
HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy.
Lind A, Akel O, Wallenius M, et al.
PloS one 2019; (14(10)):e0222882 doi:10.1371/journal.pone.0222882.
PMID: 31577807 - 5
Narcolepsy type 1: an environment-influenced disease.
Vinceti B, Fusco C, Cordelli DM, Plazzi G
Sleep medicine 2026; (146()):109034 doi:10.1016/j.sleep.2026.109034.
PMID: 42258964 - 6
Guidelines From the French-Speaking Society for Histocompatibility and Immunogenetics (SFHI) for Harmonisation of HLA Genotyping in Autoimmune Diseases, Drug Hypersensitivity and Pharmacogenetics.
Renac V, Moalic V, Dautin G, et al.
HLA 2025; (106(4)):e70442 doi:10.1111/tan.70442.
PMID: 41137743 - 7
Whole-genome analysis of monozygotic Brazilian twins discordant for type 1 narcolepsy: a case report.
Campos JHC, Aguilar ACR, Antoneli F, et al.
BMC neurology 2022; (22(1)):439 doi:10.1186/s12883-022-02921-w.
PMID: 36401198 - 8
A series of 7 cases of patients with narcolepsy with hypocretin deficiency without the HLA DQB1*06:02 allele.
Miano S, Barateau L, De Pieri M, et al.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2023; (19(12)):2053-2057 doi:10.5664/jcsm.10748.
PMID: 37539640 - 9
[NARCOLEPSY WITH CATAPLEXY: TYPE 1 NARCOLEPSY].
Dauvilliers Y, Lopez R
La Revue du praticien 2016; (66(6)):671-6.
PMID: 27538328 - 10
Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment.
Bassetti CLA, Adamantidis A, Burdakov D, et al.
Nature reviews. Neurology 2019; (15(9)):519-539 doi:10.1038/s41582-019-0226-9.
PMID: 31324898 - 11
To diagnose narcolepsy type 1 after a negative multiple sleep latency test: the contribution of systematic hypocretin measurement.
Biscarini F, Vandi S, Neccia G, et al.
Sleep 2026; (49(9)) doi:10.1093/sleep/zsag142.
PMID: 42189945 - 12
Bi-allelic variants in HCRT cause autosomal recessive narcolepsy.
Hakami W, Thabet F, Alhashem A, et al.
Neurogenetics 2024; (25(2)):79-83 doi:10.1007/s10048-024-00744-0.
PMID: 38240911
This page explains family risk and testing for narcolepsy type 1 for informational purposes only and does not constitute medical advice. A sleep specialist or genetic counselor can interpret your family history and symptoms.